TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.
6-K: Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
HUTCHMED (China) to Receive $10 Million Milestone Payment From Takeda After First European Reimbursement for Fruzaqla
Express News | Takeda Plans To Host An Investor R&D Day; Expects Six Late-Stage Programs With Peak Revenue Potential Of $10B - $20B To Deliver Sustainable Growth
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Greenhorn Dav : learn from mistakes n improve...U can do it
Arrayfunction OP Greenhorn Dav : Thanks for the encouragement!
So a big thanks to anyone else out there reading this too!
One thing I forgot to mention is how much I have always appreciated the Moomoo community. I can't remember a single time I had a negative interaction with another user. Reflecting now, that played a huge role in making me feel like I belong here and kept any big loss or dumb play make me hit the eject button.
Of all the places on the internet, who would have thought it'd be a group of stock traders where everyone gets along and respects one another?
Tonyco :